News & Trends - Biotechnology

Australian researchers’ cancer vaccine shows early promise

Health Industry Hub | July 13, 2020 |
[Total: 1    Average: 5/5]

Biotech News: Mater University of Queensland Researchers have achieved publication in the highly-ranked journal, Clinical and Translational Immunology detailing their work on a new cancer vaccine, which have shown promising signs in preclinical studies.

The vaccine was developed with support from Worldwide Cancer Research in the United Kingdom, and Mater Foundation, and could potentially be used to treat a variety of blood cancers and malignancies.

Lead Researcher Associate Professor Kristen Radford said this was a major breakthrough when it came to cancer vaccinations.

“We are hoping this could be used to treat blood cancers (myeloid leukaemia, non-Hodgkin’s lymphoma, multiple myeloma, paediatric leukaemias) plus solid malignancies including breast, lung, renal, ovarian, and pancreatic cancers, and glioblastoma,” she said.

“The team have developed a new vaccine, comprised of human antibodies fused with tumour-specific protein, and are investigating its capacity to target human cells while activating the memory of the tumour cells.”

Associate Professor Radford explains that the vaccine offers several key advantages over existing cancer vaccines that have already shown promise in early clinical trials.

“First, it can be produced as an ‘off the shelf’ clinical grade formulation, which circumvents the financial and logistical issues associated with patient-specific vaccines,” she said.

“Second, this prototype vaccine precisely targets the key tumour cells required for the initiation of tumour specific immune responses, thereby maximising potential efficacy while minimising potential side effects.

“We are very happy to see our research to be published in this prestigious journal, and we hope our continued work towards finding a safe and effective cancer vaccine will benefit cancer patients in the future.”


About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

News & Trends - Biotechnology

Biotech News - New consortium to drive Australia’s regenerative medicine future

New consortium to drive Australia’s regenerative medicine future

Health Industry Hub | October 28, 2020 |

Please log in to Health Industry Hub to view this content.
More


News & Trends - Biotechnology

Biotech News - New Board member elected for AusBiotech

New Board member elected for AusBiotech

Health Industry Hub | October 28, 2020 |

Please log in to Health Industry Hub to view this content.
More


News & Trends - Pharmaceuticals

Pharma News - AbbVie collaborates with BioCurate to commercialise Australian early stage discoveries

AbbVie collaborates with BioCurate to commercialise Australian early stage discoveries

Health Industry Hub | October 28, 2020 |

Please log in to Health Industry Hub to view this content.
More


Digital & Innovation

Healthcare Technology Digital Innovations - The big ethical questions for AI in healthcare

The big ethical questions for AI in healthcare

Health Industry Hub | October 28, 2020 |

Digital & Innovation: The use of Artificial Intelligence (AI) is advancing in every area of healthcare. It is influencing the […]

More